• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GUIDANT CRM CLONMEL IRELAND VITALITY 2; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GUIDANT CRM CLONMEL IRELAND VITALITY 2; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number T175
Device Problems Pacing Problem (1439); Inappropriate/Inadequate Shock/Stimulation (1574); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Syncope (1610)
Event Date 10/09/2014
Event Type  Injury  
Event Description
Boston scientific received information that the patient implanted with this implantable cardioverter defibrillator (icd) presented to the hospital following a syncopal episode and fall.The patient had a history of atrial fibrillation (af) with rapid ventricular response (rvr).Review of stored device memory revealed a potential episode of af with rvr where inappropriate anti-tachycardia pacing (atp) and shock therapy was delivered.Boston scientific technical services (ts) reviewed the episode and discussed therapy was delivered appropriately based on programming and detection enhancements.The cause of syncope was unable to be determined.No additional adverse patient effects were reported.The device was explanted and replaced with another manufacturer's device.
 
Manufacturer Narrative
(b)(4).The product has been received for analysis.This report will be updated upon completion of analysis.
 
Manufacturer Narrative
(b)(4).Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the device was performed.A visual inspection of the device header and case noted no anomalies.The device was then exposed to simulated heart load conditions, and the defibrillation, right ventricular pacing, and sensing functions were tested.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.Laboratory analysis did not identify any device characteristics that would have caused or contributed to the reported clinical observations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITALITY 2
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer (Section G)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer Contact
sonali vasekar
4100 hamline ave. n
st. paul, MN 55112
6515824786
MDR Report Key4396699
MDR Text Key5308825
Report Number2124215-2014-19434
Device Sequence Number1
Product Code KRG
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 11/05/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date04/06/2008
Device Model NumberT175
Other Device ID NumberVITALITY 2 VR
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/20/2014
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 11/05/2014
Initial Date FDA Received01/08/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/09/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/11/2007
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
0184; T175
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age72 YR
-
-